Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis

Clinical trial NCT06811025 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06811025
Sponsor: Beijing Chest Hospital
Status: ENROLLING_BY_INVITATION
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Tuberculosis Meningitis

Start date: 2024-02-01
Primary completion: 2025-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.